LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal

European Journal of Immunology

Volumn 28, Issue 4, 1998, Pages 1322-1331

  Le Guiner, Soizic ^a   Le Dréan, Eric ^a   Labarrière, Nathalie ^a   Fonteneau, Jean François ^a   Viret, Christophe ^b   Diez, Elisabeth ^a   Jotereau, Francine ^a,c  

^a INSERM   (France)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

Cytokine secretion; Cytotoxic T lymphocyte; Human LFA 3; Tumor immunity

Indexed keywords

CD2 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MELANOMA; RAT; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIGENS, CD58; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; RATS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031981378     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199804)28:04<1322::aid-immu1322>3.0.co;2-i     Document Type: Article

References (25)

1. Lenshow, D. J., Walunas, T. L. and Bluestone, J., CD28/B7 system of costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
2. Seventer, N. G., Shimizu, Y., Horgan, K. J. and Shaw, S., The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T-cell receptor mediated activation of resting T-cells. J. Immunol. 1990. 144: 4579-4586.
3. Moingeon, P., Chang, H. C., Wallner, B. P., Stebbins, C., Frey, A. Z. and Reinherz, E. L., CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 1989. 339: 312-314.
4. Selvaraj, P., Plunkett, M. L., Dustin, M., Sanders, M. E., Shaw, S. and Springer, T. A., The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 1987. 326: 400-403.
5. Davis, S. J. and van der Merwe, P. A., The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 1996. 17: 177-187.
6. Bierer, B. E., Peterson, A., Barbosa, J., Seed, B. and Burakoff, S. J., Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc. Natl. Acad. Sci. USA 1988. 85: 1194-1198.
7. Bierer, B. E., Peterson, A., Gorga, J. C., Herrmann, S. H. and Burakoff, S. J., Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J. Exp. Med. 1988. 168: 1145-1156.
8. Koyasu, S., Lawton, T., Novick, D., Recny, M. A., Siliciano, R. F., Wallner, B. P. and Reinherz, E. L., Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 1990. 87: 2603-2607.
9. Van de Wiel-van Kemenade, E., Te Velde, A. A., De Boer, A. J., Weening, R. S., Fischer, A., Borst, J., Melief, C. J. M. and Figdor, C. G., Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation. Eur. J. Immunol. 1992. 22: 1467-1475.
10. Altomonte, M., Gloghini, A., Bertola, G., Gasparollo, A., Carbone, A., Ferrone, S. and Maio, M., Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993. 53: 3343-3348.
11. Boussiotis, V. A., Freeman, G. J., Griffin, J. D., Gray, G. S., Gribben, J. G. and Nadler, L. M., CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 1994. 180: 1665-1673.
12. Jung, T., Schauer, U., Heusser, C., Neumann, C. and Rieger, C., Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 1993. 159: 197-207.
13. Fonteneau, J.-F., Le Dréan, E., Le Guiner, S., Gervois, N., Diez, E. and Jotereau, F., Heterogeneity of biological responses of melanoma-specific CTL. J. Immunol. 1997. 159: 2831-2839.
14. + cells. J. Exp. Med. 1997. 186: 757-766.
15. Valitutti, S., Müller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
16. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
17. Bachmann, M. F., McKall-Faienza, K., Schmits, R., Bouchard, D., Baech, J., Speiser, D. E., Mak, T. W. and Ohashi, S., Distinct role for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 1997. 7: 549-557.
18. Guilloux, Y., Lucas, S., Brichard, V., Van Pel, A., Viret, C., De Plaen, E., Brasseur, B., Lethé, F., Jotereau, F. and Boon, T., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-Acetylglucosaminyltransferase V gene. J. Exp. Med. 1996. 183: 1173-1183.
19. Coulie, P. G., Brichard, V., Van Pel, P. A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C. and Boon, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994. 180: 35-42.
20. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, T., Miki, S. L. and Rosenberg, S. A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 1994. 91: 3515-3519.
21. Gervois, N., Guilloux, Y., Diez, E. and Jotereau, F., Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med. 1996. 183: 2403-2407.
22. Beverley, B., Kang, S. M., Lenardo, M. J. and Schwartz, R. H., Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 1992. 4: 661-671.
23. Li, B. Y., Hellström, K. E., Newby, S. A. and Chen, L., Costimulation by CD48 and B7-1 Induces Immunity against Poorly Immunogenic Tumors. J. Exp. Med. 1996. 183: 639-644.
24. + cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Eur. J. Immunol. 1990. 20: 825-831.
25. Davis, L. G., Dibner, M. D. and Battey, J. F. (Eds.), Basic Methods in Molecular Biology. Elsevier, New York 1986.